OS Therapies, Inc. (NYSE-A: OSTX), a clinical-stage biotechnology company advancing immunotherapies and targeted drug conjugates for cancer treatment, today announced that it has been awarded a ...

Key data will be presented from the Company’s Phase 2b clinical trial of OST-HER2 in the prevention of recurrent, fully resected, lung metastatic osteosarcoma. This data will be compared with a ...

Ahmedabad: When 18-year-old Shyam Rawal (name changed) appears for the last Class 12 general stream exam on Saturday, it will ...

A judge agreed to allow Yolanda Perez, who was arrested by ICE, to be released on bond. The El Monte woman is the primary ...

A celebration of life service will be held for former Congressman and Houston mayor Sylvester Turner on Saturday.

Matt Torgensen ('22) had a profound impact on changing the culture. His passing in July, along with the father of head coach ...

Children's Hospital of Philadelphia (CHOP) has announced plans for Roberts Children's Health, a paediatric inpatient tower in ...

She’s like my right hand, she does everything,’ said the 20-year-old daughter, who has bone cancer and is in a wheelchair.

People with the rare Li-Fraumeni syndrome (LFS) have a high risk of developing cancer. Almost all those affected will develop ...

About OS Therapies OS Therapies is a clinical stage oncology company focused on the identification, development, and commercialization of treatments for Osteosarcoma (OS) and other solid tumors.

“Without appropriate guidance, many dogs either forget or never learn how to have basic manners, leading to problem behaviors ...